Article: Conducting The Successful European Clinical Trial

By Robert Reekie

Europe has long been an attractive location for pharmaceutical companies seeking to conduct clinical trials. With a population of 491 million, the continent offers an abundance of potential trial sites, experienced investigators, and patient populations, along with governments and local institutions eager to reap the rewards of research activity.

However, Europe presents a number of challenges to trial sponsors and CROs. While many of these challenges are well-known to the larger multinational "big pharma" companies, smaller U.S.-based companies may be less aware of them.

Used with permission from Life Science Leader magazine.

Read more...